[go: up one dir, main page]

DE69827800D1 - Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose - Google Patents

Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose

Info

Publication number
DE69827800D1
DE69827800D1 DE69827800T DE69827800T DE69827800D1 DE 69827800 D1 DE69827800 D1 DE 69827800D1 DE 69827800 T DE69827800 T DE 69827800T DE 69827800 T DE69827800 T DE 69827800T DE 69827800 D1 DE69827800 D1 DE 69827800D1
Authority
DE
Germany
Prior art keywords
shigella
diagnosis
toxin
epitope
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69827800T
Other languages
English (en)
Other versions
DE69827800T2 (de
Inventor
James Peter Burnie
Ruth Christine Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neutec Pharma Ltd
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Application granted granted Critical
Publication of DE69827800D1 publication Critical patent/DE69827800D1/de
Publication of DE69827800T2 publication Critical patent/DE69827800T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69827800T 1997-07-21 1998-07-17 Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose Expired - Lifetime DE69827800T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9715177 1997-07-21
GB9715177A GB9715177D0 (en) 1997-07-21 1997-07-21 Medicament
PCT/GB1998/002156 WO1999005169A1 (en) 1997-07-21 1998-07-17 Epitopes of shigella like toxin and their use as vaccine and in diagnosis

Publications (2)

Publication Number Publication Date
DE69827800D1 true DE69827800D1 (de) 2004-12-30
DE69827800T2 DE69827800T2 (de) 2005-11-24

Family

ID=10816080

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69827800T Expired - Lifetime DE69827800T2 (de) 1997-07-21 1998-07-17 Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose

Country Status (11)

Country Link
US (1) US6410024B1 (de)
EP (1) EP0998493B1 (de)
JP (1) JP4397523B2 (de)
AT (1) ATE283282T1 (de)
AU (1) AU747197B2 (de)
CA (1) CA2295940C (de)
DE (1) DE69827800T2 (de)
ES (1) ES2234132T3 (de)
GB (1) GB9715177D0 (de)
PT (1) PT998493E (de)
WO (1) WO1999005169A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858211B1 (en) 1998-07-20 2005-02-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccines against Escherichia coli O157 infection
JP3804791B2 (ja) 2000-06-07 2006-08-02 セイコーエプソン株式会社 インクジェット記録用インク、記録方法、記録物およびインクジェット記録装置
US20100298238A1 (en) * 2007-10-08 2010-11-25 Rutgers, The State University Nontoxic shiga-like toxin mutant compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955293A (en) * 1989-10-17 1999-09-21 New England Medical Center Hospitals, Inc. Assays for shiga toxin and shiga-like toxins
US5552144A (en) * 1992-01-22 1996-09-03 Microcarb, Inc. Immunogenic shiga-like toxin II variant mutants
NZ251621A (en) * 1992-03-26 1996-04-26 Microcarb Inc Polyclonal antibodies to shiga-like toxins
US5719064A (en) * 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
US5679564A (en) * 1994-10-05 1997-10-21 Antex Biologics, Inc. Methods for producing enhanced antigenic campylobacter bacteria and vaccines
WO1996030043A1 (en) 1995-03-24 1996-10-03 Ophidian Pharmaceuticals Treatment for verotoxin-producing escherichia coli
JP2001500730A (ja) * 1996-09-10 2001-01-23 ヘンリー エム ジャクソン ファンデーション フォージ アドバンスメント オブ ミリタリー メディシン ヒスチジン―タグ付き志賀毒素およびトキソイド、該毒素およびトキソイドとの融合タンパク質ならびにそれらの精製及び調製方法

Also Published As

Publication number Publication date
DE69827800T2 (de) 2005-11-24
PT998493E (pt) 2005-03-31
WO1999005169A1 (en) 1999-02-04
ES2234132T3 (es) 2005-06-16
AU8452098A (en) 1999-02-16
AU747197B2 (en) 2002-05-09
JP4397523B2 (ja) 2010-01-13
US6410024B1 (en) 2002-06-25
CA2295940C (en) 2010-06-15
ATE283282T1 (de) 2004-12-15
CA2295940A1 (en) 1999-02-04
GB9715177D0 (en) 1997-09-24
EP0998493B1 (de) 2004-11-24
EP0998493A1 (de) 2000-05-10
JP2001510850A (ja) 2001-08-07

Similar Documents

Publication Publication Date Title
DE69129302D1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
FR12C0004I1 (de)
ATE302411T1 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
TR200202799T3 (tr) AB peptidini sekanslayan insanlaştırılmış antikorlar
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
DE59914538D1 (de) Tetravalente Antikörperkonstrukte
IS7601A (is) Neisser-bóluefnasamsetningar sem innihalda blönduaf mótefnavökvum
DK0671927T3 (da) Neutraliserende humane monoklonale antistoffer mod respiratorisk syncytialvirus
DE69942148D1 (de) Gebrauch von bispezifischen antikörpern in diagnose und therapie
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
ZA945364B (en) Antibodies specific for human prostate glandular kallikrein
ATE303161T1 (de) Humanisierung von anti-carcinoembryonalen antigen anti-idiotypischen antikörper und dessen verwendung als tumorvakzin und zur markierung
WO2003034903A3 (en) Psma antibodies and protein multimers
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
DE602004028262D1 (de) B. pertussis antigene und ihre verwendung bei der vakzinierung
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
DE69129460D1 (de) Verwendung von Anti-ICAM Antikörpern zur Herstellung eines Präparats für die BEHANDLUNG VON ENDOTOXINSCHOCK
ATE310088T1 (de) Behandlung und nachweis von staphylokokkeninfektionen
DK1411962T3 (da) Terapi for pancreacancer med monoklonalt stof
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
DE69827800D1 (de) Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose
ATE208403T1 (de) Antiidiotypische antikörper die eine immunantwort gegen den rezeptor für epidermalen wachstumsfaktor induzieren
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
AU3637195A (en) Broadly reactive opsonic antibodies reactive with common staphylococcal antigens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition